Patient Resources
NovAssist ® - Patient Support Program Cosentyx ® NovAssist is a support program for your patients treated with Cosentyx ® . This program will help them, according to their needs and through...
NovAssist ® - Patient Support Program Cosentyx ® NovAssist is a support program for your patients treated with Cosentyx ® . This program will help them, according to their needs and through...
1. Mayzent SmPC. 2. Kappos L, Bar-Or A, Cree BAC, et al. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND...
MAYZENT® is proven to work on symptoms associated with inflammation and neurodegeneration 1,2,3,4,5*
†Exploratory end point. 1 * In EXPAND, a...
Mayzent ® is reimbursed in Belgium as from 1st November 2021.
* Detailed reimbursement criteria can be found at www.riziv.fgov.be in Dutch or...
Anne de Pauw (North)
+32473330366
Sylvie...
In patients with a CYP2C9*3*3 genotype, MAYZENT ® should not be used.
*1mg tablet will be available in Q4 2022 in Belgium – Q1 2023 in Luxembourg Procedures to request reimbursement for the 1 mg tablets...
Reimbursement for 3 types of patients
Patients insufficiently responding despite a full and adequate course of treatment with at least one first line treatment...